SMART TRENDS Study
- Conditions
- Moderate to High-risk Noncardiac Surgery
- Registration Number
- NCT05957406
- Lead Sponsor
- Edwards Lifesciences
- Brief Summary
A multicenter, interventional, feasibility comparison with historical controls
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 296
- Signed informed consent
- Age ≥ 18 years
- ASA Physical Status ≥ 2
- Elective noncardiac surgery with expected surgery duration ≥ 3 hours and expected post-operative length of stay of ≥ 3 days
- Planned monitoring with an arterial catheter; Cohort 2: without planned arterial catheter insertion
- General anesthesia with tracheal intubation and positive pressure ventilation
- Inability to comply with the study intra-operative hemodynamic management algorithm such as surgeon request for relative hypotension or fluid restriction or avoidance of vasopressors
- Planned vasopressor or inotrope infusion during surgery
- Contraindication to intra-arterial blood pressure monitoring
- Has previously participated in the SMART TRENDS study
- Serum creatine > 2.0 mg/dL (> 175 μmol/L) or CKD stage > 3A
- Scheduled for intracranial or cardiac surgery
- Patient who is known to be pregnant
- Patients on mechanical circulatory support
- Emergency surgery
- Planned beach-chair positioning
Additional Exclusion Criteria for Cohort 2 only:
- Extreme contraction of the smooth muscle in the arteries and arterioles of the lower arm and hand, such as may be present in patients with Raynaud's disease
- Finger or hand deformity that prevents proper placement of finger cuff by visual inspection
- Inability to place Acumen IQ finger cuffs due to subject anatomy, condition, or obstructive paraphernalia (such as false nails)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Primary Outcome Measures
Name Time Method HPI Smart Alert From start to end of non-cardiac surgery The proportion of HPI Smart Alert prompts displayed resulting in initiation of action within 5 minutes consistent with an intra-operative hemodynamic management algorithm.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
UC Davis Medical Center
🇺🇸Sacramento, California, United States
University of Michigan
🇺🇸Ann Arbor, Michigan, United States
Henry Ford Health System
🇺🇸Detroit, Michigan, United States
Duke University
🇺🇸Durham, North Carolina, United States
Wake Forest Baptist Medical Center
🇺🇸Winston-Salem, North Carolina, United States
Oregon Health & Science University
🇺🇸Portland, Oregon, United States
Prisma Health
🇺🇸Greenville, South Carolina, United States
University of Washington
🇺🇸Seattle, Washington, United States
UC Davis Medical Center🇺🇸Sacramento, California, United StatesAna AriasContact
